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Abstract: This study investigated the association of smoking behaviors, including dual smoking
(smoking both cigarettes and e-cigarettes), cigarettes smoking, and previous smoking, with glycated
hemoglobin (HbA1c) levels. National Health and Nutrition Examination Survey (KNHANES) data
from 2014–2016 was used. Associations between smoking behavior patterns and HbA1c levels were
analyzed via multiple regression. Among 8809 participants, individuals who were dual smokers
and cigarettes smokers had significantly higher HbA1c levels than non-smokers (dual: β = 0.1116,
p = 0.0012, single: β = 0.0752, p = 0.0022). This relationship strengthened in subgroups of men (dual:
β = 0.1290, p = 0.0013, single: β = 0.1020, p = 0.0014, ex: β = 0.0654, p = 0.0308), physically inactive
subjects (dual: β = 0.1527, p = 0.0053, single: β = 0.0876, p = 0.0197), and overweight (dual: β = 0.1425,
p = 0.0133) and obese individuals (dual: β = 0.1694, p = 0.0061, single: β = 0.1035, p = 0.0217).
This study suggests that smoking behaviors are likely to increase the risk of HbA1c level in a
general population. The health effects of dual smoking remain uncertain and should be addressed in
the future.
Keywords: HbA1c; dual smoking; type 2 diabetes mellitus; KNHANES
1. Introduction
Glycated hemoglobin (HbA1c) is used as one of the standard measures to diagnose diabetes
worldwide. HbA1c has several advantages as a diagnostic method compared with a fasting glucose
test, and has been recommended for the determination of glucose control among people who have
already diagnosed with diabetes [1–3]. The HbA1c level represents the two to three month average
blood glucose level and is therefore used to monitor glycemic control in patients with diabetes [4,5].
Cigarette smoking has been identified as a risk factor for mortality and as the second leading
risk factor for early death and disability worldwide [6]. Additionally, individuals with diabetes
who smoke are more likely to experience difficulty with insulin dosing and disease control than
non-smokers [6]. Notably, previous studies revealed that when compared to non-smokers, cigarette
smokers had elevated levels of HbA1c, as well as a 30–40% higher risk of type 2 diabetes [7–9].
Moreover, the prevalence of e-cigarette use in South Korea was 7.1% for men and 1.2% for women
in 2015, which had increased by 2.7% in men and 0.8% in women compared to 2014 [10]. Electronic
cigarettes (e-cigarettes), which aerosolize nicotine to produce a vapor that purportedly contains fewer
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traditional toxins than secondhand smoke, are used to emulate cigarette smoking. These devices
are popular for smoking cessation and reduction among those who wish to eliminate or reduce
cigarette use [11–13], and several studies have reported the positive effects of e-cigarettes for this
purpose [14,15]. However, the effects of e-cigarettes use have not been as fully elucidated as those of
cigarettes, and it remains uncertain whether these devices are safe for use by individuals interested in
smoking cessation and reduction. Moreover, dual smoking, which includes using both e-cigarettes
and ordinary cigarettes, has been revealed to likely induce tobacco dependence, although its other
health effects are still unknown [16].
Unlike evidence related to cigarette smoking, there is insufficient evidence to clarify the
relationship between dual smoking or e-cigarettes smoking and HbA1c levels. Therefore, this study
investigated the association of various smoking behaviors, including dual smoking, cigarettes alone,
and previous smoking, with HbA1c levels in a general population.
2. Methods
2.1. Study Population
This cross-sectional study was based on data from the 2014–2016 Korea National Health and
Nutrition Examination Survey (KNHANES), a nationwide survey conducted by the Korea Centers
for Disease Control (KCDC) and Prevention. From a database of 23,080 participants, we excluded
patients who had received a diagnosis of diabetes from a physician, had used medication for diabetes,
and had HbA1c levels < 6.5% (48 mmol/mol). We also excluded participants for whom information
was unavailable regarding smoking behavior, HbA1c level, age, sex, occupation, household income,
educational level, physical activity, body mass index (BMI), alcoholic behavior, pack-years of smoking,
anemia status, family history of diabetes mellitus, and caloric intake. Finally, a total of 8,809 participants
were included in this study.
2.2. Variables
The percent HbA1c was set as the dependent variable and was determined using high performance
liquid chromatography. Smoking behavior, which combined cigarette and e-cigarette use, was
the primary independent variable. The survey asked all subjects whether they used cigarettes or
e-cigarettes currently or had ever used these products during their lifetime. Accordingly, we classified
the subjects into four categories: dual smokers (both cigarettes and e-cigarette), single smokers
(cigarettes smokers), former smokers (ex-smokers), and non-smokers.
The covariates included age, sex, occupation, household income, educational level, BMI, physical
activity, pack-years of cigarette smoking, alcoholic behavior, family history of diabetes mellitus, year,
and caloric intake. Age was stratified into 10-year periods of 20–29, 30–39, 40–49, 50–59, 60–69, and
≥70 years. Socioeconomic status was stratified into four groups by household income level from
1 quartile (low) to 4 quartiles (high). Obesity was defined as a BMI ≥ 25. Physical activity, which was
self-reported, was stratified by the World Health Organization recommendations (WHO) that adults
should perform at least 150 min of moderate-intensity or 75 min of vigorous-intensity aerobic physical
activity, or an equivalent combination of both types, throughout the week. Pack year of cigarette
smoking for the lifetime was calculated by multiplying the daily smoking amount by the smoking
period by referring to the previous study. Pack-year of cigarette smoking for the lifetime was calculated
by multiplying the daily smoking amount by the smoking period by referring to the previous study
which classified this data as none, light (≤26.7 pack-years), medium (26.8–40.4 pack-years), heavy
(40.5–55.5 pack-years), and very heavy (>55.5 pack-years) [17,18]. Alcoholic behavior was defined as
the intake of such beverages above 1 times/day, 1–4 times per month, and ≥2 times/week. A family
history of diabetes was defined as having an immediate family member (e.g., father, mother, brother,
and/or sister) with type 1 or type 2 diabetes. The caloric intake was determined as the number of
kcals consumed per day, which was calculated by multiplying 4 kcal/g by intake of carbohydrates and
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protein and 9 kcal/g by intake of fat, divided by the total energy consumed during the day, and then
multiplied by 100.
2.3. Statistical Analysis
For all analyses, we used the sampling weights variable provided by KNHANES. First,
we examined the distribution of the study population in terms of the frequency and percentage of
each categorized variable, and then determined the mean and standard deviation for the distribution
of each continuous variable. The Kolmogorov-Smirnov goodness-of-fit test was used to test the
normality of distribution for HbA1c. As this variable was not normally distributed, we excluded
outliers to improve normality. Next, we used an analysis of variance (ANOVA) to compare the average
HbA1c levels according to independent variables. A multiple regression analysis including weight
as a variable was used to estimate the association between smoking behavior patterns and HbA1c
after controlling for age, sex, occupation, household income, educational level, physical activity, BMI,
alcoholic behavior, pack-years of smoking, family history of diabetes mellitus, year, and caloric intake.
Finally, we performed the multiple regression analysis of subgroups stratified by sex and physical
activity, and BMI. All statistical analyses were performed using SAS version 9.4 (SAS Institute, Inc.,
Cary, NC, USA). A p-value < 0.05 was considered statistically significant.
2.4. Ethical Statement
The Korea National Health and Nutrition Examination Survey data are openly published, thus,
ethical approval was not required for this study. This study did not require informed consent from the
participants, as their information was fully anonymized and unidentified prior to analysis.
3. Results
Table 1 presents the distribution of the study population. Regarding smoking behaviors,
dual smokers, single smokers, ex-smokers, and non-smokers accounted for 1.61% (n = 142),
15.43% (n = 1359), 18.78% (n = 1654), and 64.18% (n = 5654) of the sample, respectively. Men and
women comprised 39.99% (n = 3523) and 60.01% (n = 5286) of the sample, respectively. Normal
weight/underweight, overweight, and obese subjects comprised 46.48% (n = 4094), 22.90% (n = 2017),
and 30.63% (n = 2698) of the sample, respectively. The overall mean HbA1c level was 5.48 ± 0.27%.





Dual smokers 142 1.61 5.48 ±0.34
Single smokers 1359 15.43 5.50 ±0.27
Ex-smoker 1654 18.78 5.51 ±0.27
Non-smoker 5654 64.18 5.47 ±0.27
Sex 0.7098
Men 3523 39.99 5.50 ±0.27
Women 5286 60.01 5.48 ±0.27
Age (years) <0.0001
20–30 1176 13.35 5.26 ±0.21
30–39 1930 21.91 5.37 ±0.23
40–49 1772 20.12 5.44 ±0.23
50–59 1692 19.21 5.57 ±0.23
60–69 1314 14.92 5.65 ±0.24
≥70 925 10.50 5.70 ±0.24






Low 2821 32.02 5.45 ±0.26
Mid-low 2641 29.98 5.46 ±0.26
Mid-high 2122 24.09 5.50 ±0.27
High 1225 13.91 5.59 ±0.28
Occupational Categories 0.0913
White collar worker 2371 26.92 5.41 ±0.25
Pink collar worker 1154 13.10 5.47 ±0.26
Blue collar worker 1901 21.58 5.55 ±0.26
Unemployed 3383 38.40 5.50 ±0.28
Educational Level 0.0703
High school 4455 50.57 5.56 ±0.26
University or College 3831 43.49 5.40 ±0.25
Graduated school 523 5.94 5.42 ±0.26
BMI <0.0001
Normal/underweight (<23) 4094 46.48 5.41 ±0.25
Overweight (23–24.9) 2017 22.90 5.50 ±0.25
Obesity (≥25) 2698 30.63 5.59 ±0.27
Physical Activity 0.1061
Yes 4495 51.03 5.46 ±0.27
No 4314 48.97 5.51 ±0.27
Pack Year of Cigarette
Smoking <0.0001
Very heavy 173 1.96 5.66 ±0.28
Heavy 188 2.13 5.65 ±0.26
Medium 474 5.38 5.63 ±0.26
Light 2248 25.52 5.46 ±0.26
None 5726 65.00 5.47 ±0.27
Alcoholic Behavior <0.0001
less than 1 time for a month 3974 45.11 5.53 ±0.27
1–4 times for a month 3008 34.15 5.44 ±0.26
2 times or above for a week 1827 20.74 5.46 ±0.27
Family History of Diabetes <0.0001
Present 1986 22.55 5.52 ±0.27
Absent 6823 77.45 5.47 ±0.27
Year <0.0001
2014 2684 30.47 5.53 ±0.27
2015 2870 32.58 5.47 ±0.27
2016 3255 36.95 5.45 ±0.27
Caloric Intake † 2054.72 ±940.62
Total 8809 100.00 5.48 ±0.27
† Mean and Standard deviation (SD) of the continuous independent variables in this study.
Table 2 demonstrates the associations of smoking behavior with covariates and HbA1c levels.
Of the smoking behavior groups, dual smokers and single smokers had significantly higher HbA1c
levels than non-smokers (dual: β = 0.1116, p = 0.0012, single: β = 0.0752, p = 0.0022). HbA1c levels
tended to increase significantly with age (30–39 years: β = 0.0856, 40–49: β = 0.1538, 50–59: β = 0.2648,
60–69: β = 0.3477, and ≥70: β = 0.4147, p < 0.0001 vs. 20–29 years), BMI (overweight: β = 0.0547 and
obesity: β = 0.1457, p < 0.0001 vs. normal/underweight), education level (high school: β = 0.0218,
p = 0.0361, university or college: β = 0.0217, p = 0.0221 vs. graduated school), and physical activity
(no: β = 0.0121, p = 0.0079 vs. yes). However, household income, occupation, pack-years of cigarette
smoking, and caloric intake had no significant effect on this association.
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Table 2. The results of multiple regression analysis to investigate the association between smoking





Dual smokers 0.1116 0.0343 0.0012
Single smokers 0.0752 0.0245 0.0022
Ex-smoker 0.0261 0.0234 0.2647
Non-smoker Ref - -
Sex
Men −0.0184 0.0072 0.0114
Women Ref - -
Age (years)
20–30 Ref - -
30–39 0.0856 0.0079 <0.0001
40–49 0.1538 0.0082 <0.0001
50–59 0.2648 0.0091 <0.0001
60–69 0.3477 0.0100 <0.0001
≥70 0.4147 0.0122 <0.0001
Household Income
Low Ref - -
Mid-low 0.0062 0.0088 0.4848
Mid-high 0.0090 0.0089 0.3126
High 0.0093 0.0091 0.3096
Occupational Categories
White collar worker −0.0019 0.0061 0.7514
Pink collar worker 0.0086 0.0074 0.2426
Blue collar worker 0.0089 0.0069 0.1998
Unemployed Ref - -
Educational Level
High school 0.0218 0.0104 0.0361
University or College 0.0217 0.0095 0.0221
Graduated school Ref - -
BMI
Normal or underweight (<23) Ref - -
Overweight (23–24.9) 0.0547 0.0058 <0.0001
Obesity (≥25) 0.1457 0.0055 <0.0001
Physical Activity
Yes Ref - -
No 0.0121 0.0045 0.0079
Pack Year of Cigarette Smoking
Very heavy −0.0061 0.0315 0.8478
Heavy 0.0223 0.0294 0.4471
Medium 0.0447 0.0260 0.0861
Light −0.0163 0.0235 0.4886
None Ref - -
Alcoholic Behavior
less than 1 time for a month Ref - -
1–4 times for a month −0.0282 0.0056 <0.0001
2 times or above for a week −0.0628 0.0069 <0.0001
Family History of Diabetes
Present 0.0530 0.0056 <0.0001
Absent Ref - -
Year
2014 0.0822 0.0062 <0.0001
2015 0.0078 0.0063 0.2141
2016 Ref - -
Caloric intake 0.0000 0.0000 0.4240
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Figure 1 presents the results of subgroup analyses according to sex, physical activity, and BMI.
Men who were dual, single, and ex-smokers had significantly higher HbA1c levels, compared to
non-smokers (dual: β = 0.1290, p = 0.0013, single: β = 0.1020, p = 0.0014, ex-smoker: β = 0.654,
p = 0.0308). Among females, there was no difference in HbA1c levels across the exposure categories.
Physically inactive subjects who were dual and single smokers had significantly higher HbA1c levels
than non-smokers (dual: β = 0.1527, p = 0.0053, single: β = 0.0876, p = 0.0197). Subjects who were single
smokers and performed physical activity according to WHO recommendations also had significantly
higher HbA1c levels than non-smokers (β = 0.0672, p = 0.0344). Among obese participants, dual and
single smokers had significantly higher HbA1c levels, compared to non-smokers (dual: β = 0.1694,
p = 0.0061, single: β = 0.1035, p = 0.0217). Subjects who were dual smokers and overweight exhibited
higher HbA1c levels than non-smokers (β = 0.1425, p = 0.0133). However, there were no significant
results in normal/underweight subjects.
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Figure 1. The results of subgroup analysis with multiple regression to investigate the association between smoking behavior and HbA1c according to sex, physical 
activity, and BMI. Black bars are statistically significant results (p < 0.05). Non-smokers were the reference group. Analyses were adjusted for the following 
covariates: age, sex, occupation, household income, educational level, BMI, physical activity, pack-years of cigarette smoking, alcoholic behavior, family history of 
diabetes mellitus, year, and caloric intake.
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4. Discussion
In this study of a general population, we observed elevated HbA1c levels among subjects who
were both dual and single smokers compared to among non-smokers. These relationships were
particularly strong among male, physically inactive, and obese subjects.
Cigarette smoking has been revealed to increase HbA1c levels in patients without diabetes. One of
the previous studies revealed that cigarette smoking was associated with an increase in HbA1c in
the general population [19,20]. In addition, one study found that e-cigarettes smokers are likely to
have a high HbA1c level compared to cigarette smokers [21]. A possible explanation for this could
be the increase in the rate of glycation of HbA1c induced by exposure to glycotoxin from cigarette
smoke or the relatively high degree of tissue hypoxia [22]. Therefore, these results support our findings
regarding the effects of dual cigarette smoking in our sample. However, we were unable to determine
direct associations between e-cigarette smoking and HbA1c levels.
In the analyses stratified by sex, men who were dual and single smokers had higher HbA1c
levels than non-smokers, whereas among women, there were no significant results. Although no clear
evidence supports a link between dual smoking and increased HbA1c levels, several studies have
supported the association between cigarette smoking and HbA1c levels. One of the previous studies
revealed that cigarette smoking was independently associated with higher HbA1c concentrations
in both men and women [8]. Evidence suggests a dose-response relationship with the number of
cigarettes smoked among current smokers, and an inverse association of the number of years since
smoking cessation with HbA1c levels has been observed among male ex-smokers.
In our analysis, we also stratified smoking behaviors by physical activity levels. Among physically
inactive subjects, dual smokers who participated in both cigarette smoking and e-cigarette smoking
were more strongly associated with HbA1c levels. Potentially, lifestyle factors such as physical
inactivity and dual smoking act synergistically to elevate HbA1c levels. The ability of physical activity
to reduce HbA1c levels is well-known, and regular physical activity is recommended by healthcare
providers or professionals as a beneficial practice [23–25]. These results may corroborate our findings
of higher HbA1c levels among dual smokers who were smoking both e-cigarettes and cigarettes than
among non-smokers among physically active subjects. However, it remains unclear whether e-cigarette
smoking alone can induce an increase in more HbA1c levels. Future studies should investigate the
effects of e-cigarette use on HbA1c levels.
According to BMI, dual smokers had a strong association of elevated HbA1c levels among people
who were obese and overweight compared to those who were normal and underweight. These results
may be due to the fact that smoking is likely to increase obesity-related comorbidities associated with
visceral adiposity. Therefore, smokers tended to be obese compared to non-smokers [26]. Moreover,
a previous study revealed that visceral adiposity was associated with HbA1c [27]. We guess that
these potential biological mechanisms are underlying the strong association between dual smoking
and elevated HbA1c levels compared to non-smoking among obese people compared to normal and
underweight people.
This study had several limitations of note. First, as this was a cross-sectional study, the causal
relationship between smoking behavior patterns and HbA1c levels should be interpreted cautiously.
Second, we were not able to consider the type of e-cigarette, frequency of vaping, or concentration of
nicotine. Third, data regarding smoking behavior, health behavior, and socioeconomic status were
collected via self-report surveys and thus might have been subject to recall bias and underestimated
smoking behaviors. Fourth, caloric intake was measured indirectly. Fifth, we could not find references
about association between dual smoking and HbA1c although we tried to find previous studies.
Therefore, we could not provide enough discussion about dual smoking. Sixth, we could not consider
each single e-cigarette smoking behavior because the number of single e-cigarette smokers was very
small. Therefore, further study should consider each single smoking behavior. Finally, we may not
have fully accounted for confounding factors in our analysis.
Int. J. Environ. Res. Public Health 2018, 15, 2260 9 of 10
Despite these limitations, however, our study had several strengths. First, our analysis used
HbA1c levels which reflect average plasma glucose over the previous eight to twelve weeks and
are able to be measured at any time of day, regardless of the duration of fasting. Second, HbA1c
levels were measured using clinical tests, therefore producing reliable and clear data. Third, few other
studies have evaluated the association between smoking behavior, including e-cigarettes, and HbA1c
levels. Thus, this study might provide the impetus to seek the association between smoking behavior,
especially dual smoking, and HbA1c. Finally, our study adjusted several social factors known as
potential confounders for smoking behaviors or HbA1c, including sex, socioeconomic status, and
health behaviors, to appropriately estimate associations among smoking behavior patterns.
5. Conclusions
Smoking behaviors, especially dual smokers who use e-cigarettes and cigarettes, were found to
likely result in increased HbA1c levels in a general population, particularly among male, physically
inactive, and obese adults. This study is one of the first to attempt to examine the combined and
individual effects of cigarettes and e-cigarettes on HbA1c levels.
We note that unlike cigarettes, the health effects of dual smoking have not been fully elucidated.
Although we found that dual smoking both cigarettes and e-cigarettes is unhealthy, it remains unclear
whether e-cigarette use affects other health outcomes. Therefore, more studies should explore the
adverse health effects of e-cigarettes specifically and/or that we should educate physicians and their
patients about the risks of e-cigarettes. This may be especially important since many people believe
that e-cigarettes are “safe”.
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